Annals of Diagnostic Pathology
Volume 14, Issue 1 , Pages 60-67 , February 2010

So-called sclerosing hemangioma of lung: current concept

References 

  1. Liebow AA, Hubbell DS. Sclerosing hemangioma (histiocytoma, xanthoma) of the lung. Cancer. 1956;9:53–75
  2. Mori S. Sclerosing hemangioma of the lung. Dis Chest. 1968;54:381–384
  3. Haas JE, Yunis EJ, Totten RS. Ultrastructure of a sclerosing hemangioma of the lung. Cancer. 1972;30(2):512–518
  4. Spencer H. Sclerosing angioma of the lung (sclerosing granuloma). In: Pathology of the lung. 2nd ed.. Pergamon Press: Oxford; 1968;p. 933–937
  5. Hill GS, Eggleston JC. Electron microscopic study of so-called ‘pulmonary sclerosing hemangioma’: report of a case suggesting epithelial origin. Cancer. 1972;30:1092–1106
  6. Spencer H, Nambu S. Sclerosing haemangiomas of the lung. Histopathology. 1986;10:477–487
  7. Niho S, Suzuki K, Yokose T, Kodama T, Nishiwaki Y, Esumi H. Monoclonality of both pale cells and cuboidal cells of sclerosing hemangioma of the lung. Am J Pathol. 1998;152:1065–1069
  8. Histological typing of lung tumors. Tumori. 1981;67(4):253–272
  9. Chan KW, Gibbs AR, Lo WS, et al. Benign sclerosing pueumocytoma of lung (sclerosing haemangioma). Throax. 1982;37:404–412
  10. Devouassoux-Shisheboran M, Hayashi T, Linnoila RI, Koss MN, et al. A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting and origin from primitive respiratory epithelium. Am J Surg Pathol. 2000;24(7):906–916
  11. Leong AS, Chan KW, Seneviratne HS. A morphological and immunohistochemical study of 25 cases of so-called sclerosing haemangioma of the lung. Histopathology. 1995;27:121–128
  12. Nagata N, Dairaku M, Sueishi K, Tanaka K. Sclerosing hemangioma of the lung. An epithelial tumor composed of immunohistochemically heterogenous cells. Am J Clin Pathol. 1987;88:552–559
  13. Rodriguez-Soto J, Colby TV, Rouse RV. A critical examination of the immunophenotype of pulmonary sclerosing hemangioma. Am J Surg Pathol. 2004;24:906–916
  14. Katzenstein AL, Gmelich JT, Carrington CB. Sclerosing hemangioma of the lung: a clinicopathologic study of 51 cases. Am J Surg Pathol. 1980;4:343–356
  15. Ng WL, Ma L. Is sclerosing hemangioma of lung and alveolar mixed tumour?. Pathology. 1983;15(2):205–211
  16. Iyoda A, Hiroshima K, Shiba M, Haga Y, Moriya Y, Sekine Y, et al. Clinicopathological analysis of pulmonary sclerosing hemangioma. Ann Thorac Surg. 2004;78(6):1928–1931
  17. Kim GY, Kim J, Choi YS, Kim HJ, Ahn G, Han J. Sixteen cases of sclerosing hemangioma of the lung including unusual presentations. J Korean Med Sci. 2004;19(3):352–358
  18. Noguchi M, Kodama T, Morinaga S, Shimosato Y, Saito T, Tsuboi E. Multiple sclerosing hemangiomas of the lung. Am J Surg Pathol. 1986;10:429–435
  19. Saluja R, Pomplun S, Eisen T, Sheppard MN, Nicholson AG. Multiple combined sclerosing haemangiomas and tumourlets. A report of two patients with bilateral disease. Histopathology. 2008;53(5):614–617
  20. Fukayama M, Koike M. So-called sclerosing hemangioma of the lung. An immunohistochemical, histochemical and ultrastructural study. Acta Pathol Jpn. 1988;38(5):627–642
  21. Khoury JD, Shephard MN, Moran CA. Cystic sclerosing haemangioma of the lung. Histopathology. 2003;43(3):239–243
  22. Jin LJ, Shin BK, Jung WY, Lee HJ, Cho SJ, Han JH, et al. Proteomic analysis of pulmonary sclerosing hemangioma. Proteomics. 2006;6(17):4877–4883
  23. Dacic S, Sasatomi E, Swalsky PA, Kim DW, Finkelstein SD, Yousem SA. Loss of heterozygosity patterns of sclerosing hemangioma of the lung and bronchioloalveolar carcinoma indicate a similar molecular pathogenesis. Arch Pathol Lab Med. 2004;128(8):880–884
  24. Sartori G, Bettelli S, Schirosi L, Bigiani N, Maiorana A, Cavazza A, et al. Microsatellite and EGFR, HER2 and K-RAS analyses in sclerosing hemangioma of the lung. Am J Surg Pathol. 2007;31(10):1512–1520
  25. Chow LT, Chan SK, Chow WH, Tsui MS. Pulmonary sclerosing hemangioma. Report of a case with diagnosis by fine needle aspiration. Acta Cytol. 1992;36(3):287–292
  26. Gal AA, Nassar VH, Miller JI. Cytopathologic diagnosis of pulmonary sclerosing hemangioma. Diagn Cytopathol. 2002;26(3):163–166
  27. Iyoda A, Baba M, Saitoh H, et al. Imprint cytologic features of pulmonary sclerosing hemangioma: comparison with well-differentiated papillary adenocarcinoma. Cancer. 2002;96(3):146–149
  28. Wang SE, Nieberg RK. Fine-needle aspiration cytology of sclerosing hemangioma of the lung, a mimicker of bronchioloalveolar carcinoma. Acta Cytol. 1986;30:51–54
  29. Wojcik EM, Sneige N, Lawrence DD, Ordonez NG. Fine-needle aspiration cytology of sclerosing hemangioma of the lung: case report with immunohistochemical study. Diagn Cytopathol. 1993;9:304–309
  30. Kennedy A. ‘Sclerosing haemangioma’ of the lung: an alternative view of its development. J Clin Pathol. 1973;26(5):390
  31. Katzenstein AL, Weise DL, Fulling K, Battifora H. So-called sclerosing hemangioma of the lung. Evidence for mesothelial origin. Am J Surg Pathol. 1983;7(1):3–14
  32. Huszar M, Suster S, Herczeg E, Geiger B. Sclerosing hemangioma of the lung. Immunohistochemical demonstration of mesenchymal origin using antibodies to tissue-specific intermediate filaments. Cancer. 1986;58(11):2422–2427
  33. Xu HM, Li WH, Hou N, Zhang SG, Li HF, Wang SQ, et al. Neuroendocrine differentiation in 32 cases of so-called sclerosing hemangioma of the lung: identified by immunohistochemical and ultrastructural study. Am J Surg Pathol. 1997;21(9):1013–1022
  34. Tanaka I, Inoue M, et al. A case of pneumocytoma (so-called sclerosing hemangioma) with lymph node metastasis. Jpn J Clin Oncol. 1986;16(1):77–86
  35. Yoo SH, Jung KC, Kim JH, Sung SW, Chung JH, Shim YS, et al. Expression patterns of markers for type II pneumocytes in pulmonary sclerosing hemangiomas and fetal lung tissues. Arch Pathol Lab Med. 2005 Jul;129(7):915–919
  36. Nicholson AG, Magkou C, Snead D, Vohra HA, Sheppard MN, Goldstraw P, et al. Unusual sclerosing haemangiomas and sclerosing haemangioma-like lesions, and the value of TTF-1 in making the diagnosis. Histopathology. 2002 Nov;41(5):404–413
  37. Illei PB, Rosai J, Klimstra DS. Expression of thyroid transcription factor-1 and other markers in sclerosing hemangioma of the lung. Arch Pathol Lab Med. 2001 Oct;125(10):1335–1339
  38. Chan AC, Chan JK. Pulmonary sclerosing hemangioma consistently expresses thyroid transcription factor-1 (TTF-1): a new clue to its histogenesis. Am J Surg Pathol. 2000 Nov;24(11):1531–1536
  39. Haimoto H, Tsutsumi Y, Nagura H, Nakashima N, Watanabe K. Immunohistochemical study of so-called sclerosing haemangioma of the lung. Virchows Arch A Pathol Anat Histopathol. 1985;407(4):419–430
  40. Nagata N, Dairaku M, Ishida T, Sueishi K, Tanaka K. Sclerosing hemangioma of the lung. Immunohistochemical characterization of its origin as related to surfactant apoprotein. Cancer. 1985 Jan 1;55(1):116–123
  41. Dubilier LD, Bryant LR, Danielson GK. Histiocytoma (fibrous xanthoma) of the lung. Am J Surg. 1968 Mar;115(3):420–426

PII: S1092-9134(09)00086-0

doi: 10.1016/j.anndiagpath.2009.07.002

Annals of Diagnostic Pathology
Volume 14, Issue 1 , Pages 60-67 , February 2010

Article Tools

* Image Usage & Resolution